This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
GHB: Difference between revisions
>Adolphitus No edit summary |
>Tracer |
||
| (5 intermediate revisions by 5 users not shown) | |||
| Line 61: | Line 61: | ||
*'''[[Effect::Sleepiness]]''' & '''[[Effect::Wakefulness]]''' - At very low dosages, GHB can make one tired, while common doses are primarly wakefullness-promoting. High doses can lead to feelings of being extremely sleepy. | *'''[[Effect::Sleepiness]]''' & '''[[Effect::Wakefulness]]''' - At very low dosages, GHB can make one tired, while common doses are primarly wakefullness-promoting. High doses can lead to feelings of being extremely sleepy. | ||
*'''[[Effect::Analysis suppression]]''' | *'''[[Effect::Analysis suppression]]''' | ||
*'''[[Effect::Anxiety suppression]]''' | *'''[[Effect::Anxiety suppression]]''' | ||
*'''[[Effect::Cognitive euphoria]]''' - GHB produces intense states of euphoria comparable to that of [[cocaine]], [[MDMA]], and [[opiates]]. For this reason, it is sometimes called "liquid ecstasy". It is commonly described as a more euphoric and disinhibiting version of alcohol. While this may be accurate, it is also far easier to overdose on. | *'''[[Effect::Cognitive euphoria]]''' - GHB produces intense states of euphoria comparable to that of [[cocaine]], [[MDMA]], and [[opiates]]. For this reason, it is sometimes called "liquid ecstasy". It is commonly described as a more euphoric and disinhibiting version of alcohol. While this may be accurate, it is also far easier to overdose on. | ||
| Line 98: | Line 97: | ||
==Toxicity and harm potential== | ==Toxicity and harm potential== | ||
[[File:HarmCausedByDrugsTable.svg|thumb|upright=1.35|Table from the 2010 [[DrugScience]] study ranking various drugs (legal and illegal) based on statements by drug-harm experts. GHB was found to be the ninth overall most dangerous drug.<ref name="Nutt_2010">{{cite journal | vauthors = Nutt DJ, King LA, Phillips LD | title = Drug harms in the UK: a multicriteria decision analysis | journal = Lancet | volume = 376 | issue = 9752 | pages = 1558–1565 | date = November 2010 | pmid = 21036393 | doi = 10.1016/S0140-6736(10)61462-6 | s2cid = 5667719 | citeseerx = 10.1.1.690.1283 }}</ref>]] | |||
[[File:harmchart.png|thumb|right|300px|Radar plot showing relative physical harm, social harm, and dependence of GHB<ref>{{cite journal | vauthors=((Nutt, D.)), ((King, L. A.)), ((Saulsbury, W.)), ((Blakemore, C.)) | journal=The Lancet | title=Development of a rational scale to assess the harm of drugs of potential misuse | volume=369 | issue=9566 | pages=1047–1053 | date=24 March 2007 | url=https://www.sciencedirect.com/science/article/pii/S0140673607604644 | issn=0140-6736 | doi=10.1016/S0140-6736(07)60464-4}}</ref>]] | [[File:harmchart.png|thumb|right|300px|Radar plot showing relative physical harm, social harm, and dependence of GHB<ref>{{cite journal | vauthors=((Nutt, D.)), ((King, L. A.)), ((Saulsbury, W.)), ((Blakemore, C.)) | journal=The Lancet | title=Development of a rational scale to assess the harm of drugs of potential misuse | volume=369 | issue=9566 | pages=1047–1053 | date=24 March 2007 | url=https://www.sciencedirect.com/science/article/pii/S0140673607604644 | issn=0140-6736 | doi=10.1016/S0140-6736(07)60464-4}}</ref>]] | ||
| Line 162: | Line 162: | ||
*'''New Zealand:''' GHB, 1,4-B and GBL are all Class B illegal drugs, along with any possible esters, ethers and aldehydes.{{citation needed}} | *'''New Zealand:''' GHB, 1,4-B and GBL are all Class B illegal drugs, along with any possible esters, ethers and aldehydes.{{citation needed}} | ||
*'''Norway:''' GHB is considered a narcotic and is only available by prescription under the trade name Xyrem.{{citation needed}} | *'''Norway:''' GHB is considered a narcotic and is only available by prescription under the trade name Xyrem.{{citation needed}} | ||
*'''Romania''': GHB is considered a Schedule I illegal drug.<ref>https://legislatie.just.ro/Public/DetaliiDocument/23629</ref> | |||
*'''Switzerland:''' GHB is a controlled substance specifically named under Verzeichnis A. Medicinal use is permitted.<ref>{{cite web|url=https://www.admin.ch/opc/de/classified-compilation/20101220/index.html|title=Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien|publisher=Bundeskanzlei [Federal Chancellery of Switzerland]|access-date=January 1, 2020|language=de}}</ref> | *'''Switzerland:''' GHB is a controlled substance specifically named under Verzeichnis A. Medicinal use is permitted.<ref>{{cite web|url=https://www.admin.ch/opc/de/classified-compilation/20101220/index.html|title=Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien|publisher=Bundeskanzlei [Federal Chancellery of Switzerland]|access-date=January 1, 2020|language=de}}</ref> | ||
*'''United Kingdom:''' GHB was made a Class C drug in June 2003.{{citation needed}} | *'''United Kingdom:''' GHB was made a Class C drug in June 2003.{{citation needed}} | ||
| Line 179: | Line 180: | ||
*[https://www.erowid.org/chemicals/ghb/ghb.shtml GHB (Erowid Vault)] | *[https://www.erowid.org/chemicals/ghb/ghb.shtml GHB (Erowid Vault)] | ||
*[https://isomerdesign.com/PiHKAL/explore.php?id=12265 GHB (Isomer Design)] | *[https://isomerdesign.com/PiHKAL/explore.php?id=12265 GHB (Isomer Design)] | ||
*[https://drugs-forum.com/wiki/GHB GHB (Drugs-Forum)] | |||
==References== | ==References== | ||
| Line 184: | Line 186: | ||
[[Category:Neurotransmitter]] | [[Category:Neurotransmitter]] | ||
[[Category: | [[Category:Gamma-Hydroxy acid]] | ||
[[Category:Depressant]] | [[Category:Depressant]] | ||
{{#set:Featured=true}} | {{#set:Featured=true}} | ||